Upbeat Drug Data Has Galmed Stock Scaling Nasdaq – Schaeffers Research (blog)

This post was originally published on this site


Schaeffers Research (blog)

Upbeat Drug Data Has Galmed Stock Scaling Nasdaq
Schaeffers Research (blog)
Those looking to bet on SAGE stock’s short-term price action may want to consider doing so with options. The equity’s Schaeffer’s Volatility Index (SVI) of 49% ranks in the 2nd annual percentile, meaning low volatility expectations are being priced

and more »

Leave a Reply